Prior Auth Required

0422U - quantitative change from baseline, including specific alterations, if appropriate

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicequantitative change from baseline, including specific alterations, if appropriate
Procedure / Service Description

Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using - cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a 0422U quantitative change from baseline, including specific alterations, if appropriate Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 0423U genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.